Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Mahender Nayak

Tracked across 2 events · 113 articles · First seen Jul 20, 2026 · Last active Sep 18, 2026

Sentiment
0
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 0
Regulatory
Impact: Mahender Nayak, Head of Intercontinental Markets at Takeda, announced the approval and highlighted the vaccine's potential impact on dengue prevention in India.
Jul 20, 2026 · 93 articles
3 0
Business
Abbott Laboratories and Takeda Pharmaceutical Company announced on September 18, 2026 an exclusive distribution agreement under which Dr. Reddy's will promote and distribute Takeda's dengue vaccine QDENGA across India's private market for pediatric and adult…
Impact: As Takeda's Head of Intercontinental Markets, Mahender Nayak represented Takeda in announcing the collaboration and welcomed the Parliamentary Committee on Health's recommendation on dengue vaccination.
Sep 18, 2026 · 20 articles
ERGEN INTELLIGENCE
Track Mahender Nayak live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.